Martin Mackay Spring Works Therapeutics, Inc. (SWTX) insider trading activity

SWTX Quotes by TradingView

Martin Mackay is Director of SpringWorks Therapeutics, Inc.. Currently has a direct ownership of 0 shares of SWTX, which is worth approximately $0. The most recent transaction as insider was on Jul 01, 2025, when has been sold 20,023 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
n/a 12M change
Total Value Held $0

MARTIN MACKAY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2025
SELL
Sale (or disposition) back to the issuer
-
20,023 Reduced 100.0%
0 Common Stock
May 14 2025
BUY
Grant, award, or other acquisition
-
10,060 Added 33.44%
20,023 Common Stock
Jul 29 2024
BUY
Grant, award, or other acquisition
-
9,963 Added 50.0%
9,963 Common Stock

Also insider at

CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Healthcare
Director
RLYB
Rallybio Corp Healthcare
Director
FVAM
5:01 Acquisition Corp. Financial Services
Director
MM

Martin Mackay

Director
Wilmington, MA

Track Institutional and Insider Activities on SWTX

Follow SpringWorks Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SWTX shares.

Notify only if

Insider Trading

Get notified when an Spring Works Therapeutics, Inc. insider buys or sells SWTX shares.

Notify only if

News

Receive news related to SpringWorks Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SWTX